Yep. The interesting thing is that mica constent and recovery rates are not improving (or are getting worse). Also take away the funds from share issues and the cash position ain’t great. Production costs still too high.
- Forums
- ASX - By Stock
- GXY
- Ann: Quarterly Reports - December 2017
Ann: Quarterly Reports - December 2017, page-203
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online